Skip to main navigation
Plx Pharma logo

SEC Filings

Plx Pharma logo Plx Pharma logo Plx Pharma logo Plx Pharma logo
  • Home
  • About Us
    • About Us
    • Our Story
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Our Technology
    • Our Technology
    • VazaloreTM
    • Pipeline
    • Publications
  • Investors
  • FAQS
  • Contact
Plx Pharma logo Plx Pharma logo Plx Pharma logo Plx Pharma logo
  • Home
  • About Us
    • About Us
    • Our Story
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Our Technology
    • Our Technology
    • VazaloreTM
    • Pipeline
    • Publications
  • Investors
  • FAQS
  • Contact
Plx Pharma logo Plx Pharma logo Plx Pharma logo Plx Pharma logo
  • Home
  • About Us
    • About Us
    • Our Story
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Our Technology
    • Our Technology
    • VazaloreTM
    • Pipeline
    • Publications
  • Investors
  • FAQS
  • Contact
Plx Pharma logo Plx Pharma logo Plx Pharma logo Plx Pharma logo
  • Home
  • About Us
    • About Us
    • Our Story
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Our Technology
    • Our Technology
    • VazaloreTM
    • Pipeline
    • Publications
  • Investors
  • FAQS
  • Contact
Plx Pharma logo Plx Pharma logo Plx Pharma logo Plx Pharma logo
  • Home
  • About Us
    • About Us
    • Our Story
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Our Technology
    • Our Technology
    • VazaloreTM
    • Pipeline
    • Publications
  • Investors
  • FAQS
  • Contact
Plx Pharma logo Plx Pharma logo Plx Pharma logo Plx Pharma logo
  • Home
  • About Us
    • About Us
    • Our Story
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Our Technology
    • Our Technology
    • VazaloreTM
    • Pipeline
    • Publications
  • Investors
  • FAQS
  • Contact
  • Home
  • About Us
    • About Us
    • Our Story
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Our Technology
    • Our Technology
    • VazaloreTM
    • Pipeline
    • Publications
  • Investors
  • FAQS
  • Contact
Investor Menu
  • Overview
  • News Releases
  • Events & Presentations
    • Events
    • Presentations
  • Stock
    • Stock Quote & Chart
    • Historical Price Lookup
    • Analyst Coverage
  • Governance
    • Document & Charters
    • Committee Composition
  • Financials
    • SEC Filings
    • Financial Results
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

SEC Filings

Filing date Form Description Filing Group View
January 20, 2023 8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
0001193805-23-000070.pdf
0001193805-23-000070.rtf
0001193805-23-000070.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
November 10, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
0001437749-22-026958.pdf
0001437749-22-026958.rtf
0001437749-22-026958.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
November 10, 2022 8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
0001193805-22-001510.pdf
0001193805-22-001510.rtf
0001193805-22-001510.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
October 7, 2022 8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
0001193805-22-001341.pdf
0001193805-22-001341.rtf
0001193805-22-001341.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
September 29, 2022 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
View HTML
0000921895-22-002725.pdf
0000921895-22-002725.rtf
0000921895-22-002725.xls
September 29, 2022 DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
0000921895-22-002726.pdf
0000921895-22-002726.rtf
0000921895-22-002726.xls
August 12, 2022 8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
0001193805-22-001162.pdf
0001193805-22-001162.rtf
0001193805-22-001162.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
August 12, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
0001437749-22-020233.pdf
0001437749-22-020233.rtf
0001437749-22-020233.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 13, 2022 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
View HTML
0001437749-22-012225.pdf
0001437749-22-012225.rtf
0001437749-22-012225.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 13, 2022 8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
0001193805-22-000785.pdf
0001193805-22-000785.rtf
0001193805-22-000785.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Displaying 1 - 10 of 304 results

Data provided by Kaleidoscope.

  • Print Page
  • RSS Feeds
  • Email Alerts
Plx Pharma logo

Quick Links

  • Privacy Policy
  • Terms and Conditions
  • Site Map
  • Contact Us

Contacts

  • info@plxpharma.com
  • (973) 409-6541
  • (973) 843-6300
  • 9 Fishers Lane, Suite E
    Sparta, NJ 07871

© 2023 PLx Pharma Inc. All rights reserved.